Immunohistochemical determination of the growth hormone receptor in squamous cell carcinoma of the skin

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 13, Issue 1, 2004, Pages 3-8

  Stanimirović, Andrija ^a   Čupić, Hrvoje ^a   Tomas, Davor ^a   Bošnjak, Berislav ^b   Baličević, Drinko ^a   Krušlin, Bozo ^a   Belicza, Mladen ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b PLIVA Research Institute Ltd   (Croatia)

Author keywords

Growth hormone receptor; Immunohistochemistry; Skin squamous cell carcinoma

Indexed keywords

GROWTH HORMONE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CELL COUNT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SKIN CARCINOMA; SKIN DEFECT; SQUAMOUS CELL CARCINOMA;

EID: 1842783443     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: S4-S7.
2. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 1989; 262: 2097-100.
3. Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer 1990; 26: 356-61.
4. Ananthaswamy HN, Ullrich SE, Mascotto RE, Fourtanier A, Loughlin SM, Khaskina P, Bucana CD, Kripke ML. Inhibition of solar simulator-induced p53 mutations and protection against skin cancer development in mice by sunscreens. J Invest Dermatol 1999; 112(5): 763-8
5. Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: S8-S10.
6. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma JA, Kimmelman J, Remington L, Jacks T, Brash DE. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372: 773-6.
7. Leffell DJ. The scientific basis of skin cancer. J Am Acad Dermatol 2000; 42: S18-S22.
8. Rosembloom AL, Guevara-Aguirre J, Fielder PJ, et al. Laron syndrome (growth hormone deficiency) in Ecuador: clinical and biochemical characteristics. In: Laron Z, Parks JS. Lessons from Laron syndrome (LS) 1966-92. Pediatric and adolescent endocrinology, Karger, Basel. 1993: 24-34.
9. Lobie PE, Breipohl W, Lincoln DT, Garcia-Aragon J, Waters MJ. Localization of the growth hormone receptor/binding protein in skin. J Endocrinol 1990; 126: 467-72
10. Tavakkol A, Elder JT, Griffiths CEM, Cooper KD, Talwar H, Fisher GJ, Keane KM, Foltin SK, Voorhees JJ. Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol 1992; 99: 343-9.
11. Oakes SR, Haynes KM, Waters MJ, Herington AC, Werther GA. Demonstration and localization of growth hormone receptor in human skin and skin fibroblasts. J Clin Endocrinol Metab 1992; 75: 1368-73.
12. Lincoln DT, Sinowatz F, Temmim-Baker L, Baker HI, Kölle S, Waters MJ. Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells. Histochem Cell Biol 1998; 109: 141-59
13. Ginarte M, García-Cabarello T, Fernández-Redondo V, Beiras A, Toribio J. Expression of growth hormone receptor in benign and malignant cutaneous proliferative entities. J Cutan Pathol 2000; 27: 276-82.
14. Stanimirović A, Čupić H, Bošnjak B, Krušlin B, Belicza M. Expression of p53, bcl-2 and growth hormone receptor in actinic keratosis, hypertrophic type. Arch Dermatol Res 2003; 295: 102-8.
15. Stanimirović A, Čupić H, Bośnjak B, Tomas D, Baličević D, Krušlin B, Belicza M. Expression of p53, bcl-2 and growth hormone receptor in atrophic type of actinic keratosis. J Dermatol Sci 2004; 34: 49-53.